Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Request metadata listed "Astronova, Inc.", but filing text confirms "Astro-Med, Inc.")
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended May 4, 1996
Business Overview: The company manufactures medical instrumentation, including traditional recorder products, Grass Instrument lines, and newer product lines such as Bar Code, SUNDANCE, and K3 systems.
Key Financial Metrics
| Metric | Q1 1996 (Ended May 4) | Q1 1995 (Ended April 29) |
|---|---|---|
| Net Sales | $10,489,822 | $10,955,296 |
| Gross Profit | $3,958,296 | $4,243,026 |
| Gross Margin | 38% | 39% |
| Operating Income | $1,110 | $189,329 |
| Net Income | $443,111 | $342,053 |
| Earnings Per Share | $0.09 | $0.07 |
| Cash and Equivalents (End of Period) | $4,822,326 | $1,168,474 |
| Net Cash from Operating Activities | $1,601,871 | $186,613 |
| Total Debt (Current + Long-Term) | $200,000 | $200,000 (implied from prior period trends) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 4% year-over-year, driven by lower volume in traditional recorder products and certain Grass Instrument lines.
- Margin Compression: Gross profit margin slipped from 39% to 38% due to product mix shifts, though management expects improvement as new products gain market share.
- Operating Income Drop: Operating income fell significantly to $1,110 from $189,329, primarily due to the revenue decline and margin pressure.
- Net Income Increase: Despite lower operating income, Net Income rose 30% to $443,111. This was driven by a substantial increase in Investment Income ($519,039 vs. $99,224), largely due to gains from the sale of securities.
- Cash Flow Surge: Net cash provided by operating activities increased to $1.6 million from $186,613, aided by a $1.67 million reduction in accounts receivable.
- Liquidity: Cash and cash equivalents more than doubled to $4.82 million, bolstered by net cash inflows from investing activities ($1.78 million) due to net sales of securities.
Guidance, Outlook, and Risks
- Growth Strategy: Management expects growth to be driven by new product lines (Bar Code, SUNDANCE, K3), which reported double-digit growth rates. International sales increased 22%.
- Margin Outlook: Gross profit margins are expected to improve as new printers and data acquisition products increase market penetration.
- Capital Needs: The company states that current cash, investment securities, and operating funds are sufficient to meet working capital and other needs for the foreseeable future. No additional long-term financing is planned.
- Debt Structure: Long-term debt consists of the remainder of an industrial development revenue bond used for prior facility construction and equipment acquisitions.
- Shareholder Action: A Non-Employee Director Stock Option Plan was approved by shareholders at the May 21, 1996 annual meeting.
Investor Verification Checklist
- Sustainability of Investment Gains: Verify if the $416,090 gain on the sale of investments is a one-time event or indicative of a recurring strategy, as it was the primary driver of net income growth.
- Product Mix Transition: Monitor the trajectory of sales in traditional recorder products versus new product lines to confirm the expected margin improvement.
- Accounts Receivable Quality: Investigate the $1.67 million decrease in accounts receivable to ensure it reflects strong collections rather than a change in credit policy or sales timing.
- Inventory Levels: Review the slight increase in inventory ($12.5M to $12.7M) against the sales decline to ensure no obsolescence risks exist for older product lines.